Clinical Trial Update: Efficacy of Injection Sekucinumab in Erythrodermic Psoriasis

View source ↗

Summary

This clinical trial entry notes a study evaluating injections of Sekucinumab for erythrodermic psoriasis, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythrodermic Psoriasis

Drugs mentioned

• Sekucinumab (Sekucinumab)

Snippet

Sponsor: Jinnah Postgraduate Medical Centre | Conditions: Erythrodermic Psoriasis | Status: NOT_YET_RECRUITING